-
Constructing a Dynamic Budget Impact Model: An AI Pretraining Approach for a New Parkinson's Disease Drug
Sep 9, 2025, 16:22 PM -
Incidence of Intracerebral Hemorrhage in Patients With Mild Cognitive Impairment or Alzheimer’s Dementia Among United States Medicare Beneficiaries
Sep 9, 2025, 16:22 PM -
Characteristics of Real-World Data Landscape in Italy: A Scoping Review
Sep 9, 2025, 16:22 PM -
Designing Digital Healthcare Professional Surveys: A Methodological Overview
Sep 9, 2025, 16:22 PM -
Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-offs
Sep 9, 2025, 16:22 PM -
A Comparison of the Potential Public Health Impact of PCV15 and PCV20 in French Infants
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Costs Associated With Malignant Brain Tumors in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Examining Knowledge Regarding Needlestick Injuries Among Students in Higher Healthcare Education
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients With Treatment Failure After C5 Inhibitor Therapy: An Analysis From the Brazilian Public Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
Epidemiology of Breast Cancer in France
Sep 9, 2025, 16:22 PM -
CAR-T Therapy in Asia-Pacific: Is It Reimbursed in Your Country?
Sep 9, 2025, 16:22 PM -
Economic and Clinical Insights Into Oral Nutritional Supplementation in Oncology: A Brazilian Real-World Study
Sep 9, 2025, 16:22 PM -
Applying the Evidence-Generation Continuum Concept to Support Patient Access to Innovative Therapies in France: A Use Case in Rare Diseases
Sep 9, 2025, 16:22 PM -
The Czech Republic’s Dedicated Orphan Drug Reimbursement Mechanism 2022-2025: Improvements in Access
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Atopic Dermatitis in Poland in Comparison With Efficacy Reported in Clinical Trials
Sep 9, 2025, 16:22 PM -
Reevaluating Cost-Effectiveness: A Holistic Framework for Assessing Disease-Modifying Treatments in Type 1 Diabetes
Sep 9, 2025, 16:22 PM -
Rescaled Tariff Regression for EQ-5D-5L Health State Valuation: An Equivalent Alternative to the Nonparametric Crosswalk
Sep 9, 2025, 16:22 PM -
Burden of Illness and Healthcare Resource Utilization Among Patients Newly Diagnosed With Amyotrophic Lateral Sclerosis in the United States: A Retrospective, Observational, Cohort Design Study
Sep 9, 2025, 16:22 PM -
Clinical and Economic Benefits of Extended-Release Metformin In Prediabetes Management
Sep 9, 2025, 16:22 PM -
A Proof of Concept Study to Build a Japanese-Based Electronic Medical Record Data Model Suited for Real-World Research
Sep 9, 2025, 16:22 PM
